Zacks Investment Research
12 Mar 2026, 22:11 UTC · 27w ago
Verdict
Headline takes no side. We score SKIN +0.20 across three claims — slightly bullish.
+0.20slightly bullish
More positive than 52% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
The Beauty Health Company (SKIN) reported a quarterly loss of $0.06 per share, beating the Zacks Consensus Estimate of a $0.07 loss.
More positive than 50% of claims this week
Beauty Health reported quarterly revenues of $82.4 million, surpassing the Zacks Consensus Estimate by 5.42%.
So whatRevenue growth exceeding expectations suggests stable demand, but it is offset by a year-over-year decline from $83.5 million.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 45% of claims this week
Beauty Health shares have declined approximately 19.1% since the beginning of the year, significantly underperforming the S&P 500.
More negative than 66% of claims this week
Which stocks this story touches
More positive than 52% of ticker scores this week
The company reported an earnings and revenue beat for the quarter, although it remains unprofitable and has underperformed the market.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−36.2%
Price is moving against the score
$0.6767 vs $1.06 close before publication (Mar 12) · not market-adjusted
SKIN chart →
